{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:44:43Z","timestamp":1790372683425,"version":"4.1.0"},"reference-count":271,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2022-293"],"award-info":[{"award-number":["075-15-2022-293"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.neubiorev.2024.105794","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T12:32:44Z","timestamp":1720096364000},"page":"105794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Intricacies of aging and Down syndrome"],"prefix":"10.1016","volume":"164","author":[{"given":"G.","family":"Kozlov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vedunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib1","doi-asserted-by":"crossref","first-page":"e1382","DOI":"10.1542\/peds.2011-1262","article-title":"Lipid profiles of children with Down syndrome compared with their siblings","volume":"129","author":"Adelekan","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib2","first-page":"118","article-title":"Economy and preferred speed of walking in adults with and without Down syndrome","volume":"26","author":"Agiovlasitis","year":"2009","journal-title":"Adapt Phys. Act. Q"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10571-017-0514-0","article-title":"Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease","volume":"38","author":"Alexandrov","year":"2018","journal-title":"Cell Mol. Neurobiol."},{"issue":"20","key":"10.1016\/j.neubiorev.2024.105794_bib4","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.3390\/jcm10204687","article-title":"Aging with Down Syndrome-Where Are We Now and Where Are We Going?","volume":"10","author":"Alldred","year":"2021","journal-title":"J. Clin. Med"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10072-020-04880-x","article-title":"Down's syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach.","volume":"42","author":"Altable","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2024.105794_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nbd.2012.11.017","article-title":"Normalization of Dyrk1A expression by AAV2\/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome","volume":"52","author":"Altafaj","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/dnares\/dsv016","article-title":"Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures","volume":"22","author":"Amano","year":"2015","journal-title":"DNA Res"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ng0293-146","article-title":"Mitotic errors in somatic cells cause trisomy 21 in about 4.5% of cases and are not associated with advanced maternal age","volume":"3","author":"Antonarakis","year":"1993","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neubiorev.2024.105794_bib9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrg1448","article-title":"Chromosome 21 and Down syndrome: from genomics to pathophysiology","volume":"5","author":"Antonarakis","year":"2004","journal-title":"Nat. Rev. Genet"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib10","first-page":"544","article-title":"The meiotic stage of nondisjunction in trisomy 21: determination by using DNA polymorphisms","volume":"50","author":"Antonarakis","year":"1992","journal-title":"Am. J. Hum. Genet"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"48","key":"10.1016\/j.neubiorev.2024.105794_bib12","doi-asserted-by":"crossref","first-page":"24231","DOI":"10.1073\/pnas.1908129116","article-title":"Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity","volume":"116","author":"Araya","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2024.105794_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2018.09.010","article-title":"DYRK1A and cognition: A lifelong relationship","volume":"194","author":"Arbones","year":"2019","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.neubiorev.2024.105794_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12929-015-0138-y","article-title":"Down syndrome: an insight of the disease","volume":"22","author":"Asim","year":"2015","journal-title":"J. Biomed. Sci."},{"issue":"8","key":"10.1016\/j.neubiorev.2024.105794_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/dmcn.14260","article-title":"New approaches to studying early brain development in Down syndrome","volume":"61","author":"Baburamani","year":"2019","journal-title":"Dev. Med Child Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.18632\/aging.100715","article-title":"Identification of a DNA methylation signature in blood cells from persons with Down Syndrome","volume":"7","author":"Bacalini","year":"2015","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s11357-021-00347-9","article-title":"Ageing affects subtelomeric DNA methylation in blood cells from a large European population enrolled in the MARK-AGE study","volume":"43","author":"Bacalini","year":"2021","journal-title":"Geroscience"},{"key":"10.1016\/j.neubiorev.2024.105794_bib18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nature08062","article-title":"Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1","volume":"459","author":"Baek","year":"2009","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105794_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/genes9090429","article-title":"Profiling DNA Methylation Based on Next-Generation Sequencing Approaches: New Insights and Clinical Applications","volume":"9","author":"Barros-Silva","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.neubiorev.2024.105794_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pharmtox-041521-103641","article-title":"Prenatal and Postnatal Pharmacotherapy in Down Syndrome: The Search to Prevent or Ameliorate Neurodevelopmental and Neurodegenerative Disorders","volume":"62","author":"Bartesaghi","year":"2022","journal-title":"Annu Rev. Pharm. Toxicol."},{"issue":"16","key":"10.1016\/j.neubiorev.2024.105794_bib21","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/9.16.2395","article-title":"The DNA methyltransferases of mammals","volume":"9","author":"Bestor","year":"2000","journal-title":"Hum. Mol. Genet"},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105794_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112023","article-title":"Gut microbiome in Down syndrome","volume":"9","author":"Biagi","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jpeds.2009.12.006","article-title":"Distinct abnormalities in the innate immune system of children with Down syndrome","volume":"156","author":"Bloemers","year":"2010","journal-title":"J. Pedia"},{"issue":"10","key":"10.1016\/j.neubiorev.2024.105794_bib24","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1021\/acs.jproteome.5b00356","article-title":"Plasma N-Glycome Signature of Down Syndrome","volume":"14","author":"Borelli","year":"2015","journal-title":"J. Proteome Res"},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065373","article-title":"Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia","volume":"8","author":"Borss\u00e9n","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2024.105794_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnagi.2019.00177","article-title":"The Precursor to Glutathione (GSH), \u03b3-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by A\u03b240 Oligomers in Human Astrocytes","volume":"11","author":"Braidy","year":"2019","journal-title":"Front Aging Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004836-198604000-00002","article-title":"Down's syndrome and the gastrointestinal tract","volume":"8","author":"Buchin","year":"1986","journal-title":"J. Clin. Gastroenterol."},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105794_bib28","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1089\/ars.2009.3074","article-title":"Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders","volume":"13","author":"Calabrese","year":"2010","journal-title":"Antioxid. Redox Signal"},{"issue":"10","key":"10.1016\/j.neubiorev.2024.105794_bib29","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","article-title":"Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity","volume":"8","author":"Calabrese","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105794_bib30","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1024984013069","article-title":"Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine","volume":"28","author":"Calabrese","year":"2003","journal-title":"Neurochem Res"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib31","first-page":"205","article-title":"Mental and motor development in young mongol children","volume":"14","author":"Carr","year":"1970","journal-title":"J. Ment. Defic. Res"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib32","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1044\/jslhr.4105.1125","article-title":"Gestures and words in early development of children with Down syndrome","volume":"41","author":"Caselli","year":"1998","journal-title":"J. Speech Lang. Hear Res"},{"key":"10.1016\/j.neubiorev.2024.105794_bib33","series-title":"Biomedical concerns in persons with Down syndrome","first-page":"59","article-title":"Opthalmologic concerns","author":"Catalano","year":"1992"},{"key":"10.1016\/j.neubiorev.2024.105794_bib34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fphar.2015.00305","article-title":"Ferulic Acid Regulates the Nrf2\/Heme Oxygenase-1 System and Counteracts Trimethyltin-Induced Neuronal Damage in the Human Neuroblastoma Cell Line SH-SY5Y","volume":"6","author":"Catino","year":"2016","journal-title":"Front Pharm."},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105794_bib35","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1007\/s10803-019-04074-1","article-title":"Characteristics Associated with Autism Spectrum Disorder Risk in Individuals with Down Syndrome","volume":"49","author":"Channell","year":"2019","journal-title":"J. Autism Dev. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P","article-title":"Behavioral phenotype of individuals with Down syndrome","volume":"6","author":"Chapman","year":"2000","journal-title":"Ment. Retard Dev. Disabil. Res Rev."},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105794_bib37","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1007\/s10072-022-06238-x","article-title":"COVID-19 infection and Down syndrome-challenges and future directions for care in children","volume":"43","author":"Chauhan","year":"2022","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib38","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ijporl.2014.03.012","article-title":"A general review of the otolaryngologic manifestations of Down Syndrome","volume":"78","author":"Chin","year":"2014","journal-title":"Int J. Pedia Otorhinolaryngol."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000212622","article-title":"Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects","volume":"30","author":"Chiricolo","year":"1984","journal-title":"Gerontology"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0921-8734(93)90012-R","article-title":"Enhanced DNA repair in lymphocytes of Down syndrome patients: the influence of zinc nutritional supplementation","volume":"295","author":"Chiricolo","year":"1993","journal-title":"Mutat. Res"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib41","first-page":"387","article-title":"Hematopoietic disorders in Down syndrome","volume":"1","author":"Choi","year":"2008","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib42","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/gerona\/glx198","article-title":"DNA Hydroxymethylation Levels Are Altered in Blood Cells From Down Syndrome Persons Enrolled in the MARK-AGE Project","volume":"73","author":"Ciccarone","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"10.1016\/j.neubiorev.2024.105794_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2017.04.006","article-title":"Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline","volume":"56","author":"Cole","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib44","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/gerona\/gly153","article-title":"Human Aging and Longevity Are Characterized by High Levels of Mitokines","volume":"74","author":"Conte","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"issue":"8","key":"10.1016\/j.neubiorev.2024.105794_bib45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/hipo.20308","article-title":"Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice","volume":"17","author":"Contestabile","year":"2007","journal-title":"Hippocampus"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/imm.12659","article-title":"The contribution of the citrate pathway to oxidative stress in Down syndrome","volume":"149","author":"Convertini","year":"2016","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105794_bib47","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00204-016-1843-3","article-title":"Risk factors for Down syndrome","volume":"90","author":"Copped\u00e8","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib48","first-page":"241","article-title":"Exposure to low-frequency pulsed electromagnetic fields increases mitogen-induced lymphocyte proliferation in Down's syndrome. Aging (Milano)","volume":"3","author":"Cossarizza","year":"1991"},{"key":"10.1016\/j.neubiorev.2024.105794_bib49","first-page":"213","article-title":"Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers","volume":"7","author":"Cossarizza","year":"1990","journal-title":"Am. J. Med Genet Suppl."},{"issue":"1-3","key":"10.1016\/j.neubiorev.2024.105794_bib50","first-page":"163","article-title":"Fetal thymic differentiation in Down's syndrome","volume":"14","author":"Cossarizza","year":"1989","journal-title":"Thymus"},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib51","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood.V77.6.1263.1263","article-title":"Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome","volume":"77","author":"Cossarizza","year":"1991","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib52","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0361-9230(86)90074-2","article-title":"The neurobiologic consequences of Down syndrome","volume":"16","author":"Coyle","year":"1986","journal-title":"Brain Res Bull."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1081-1206(10)60516-9","article-title":"Follow-up study of immune defects in patients with dysmorphic disorders","volume":"102","author":"Cruz","year":"2009","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","article-title":"The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome","volume":"6","author":"Davidson","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib55","first-page":"1281","article-title":"Cu\/Zn-superoxide dismutase and glutathione peroxidase during aging","volume":"35","author":"de Haan","year":"1995","journal-title":"Biochem Mol. Biol. Int"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mnfr.201300325","article-title":"Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans","volume":"58","author":"De la Torre","year":"2014","journal-title":"Mol. Nutr. Food Res"},{"key":"10.1016\/j.neubiorev.2024.105794_bib57","series-title":"Genetics and Etiology of Down Syndrome","article-title":"Down Syndrome: A Complex and Interactive Genetic Disorder","author":"Deitz","year":"2011"},{"key":"10.1016\/j.neubiorev.2024.105794_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neubiorev.2014.05.004","article-title":"Epigenetics: the neglected key to minimize learning and memory deficits in Down syndrome","volume":"45","author":"Dekker","year":"2014","journal-title":"Neurosci. Biobehav Rev."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77392-5","article-title":"Gestational age is related to symptoms of attention-deficit\/hyperactivity disorder in late-preterm to full-term children and adolescents with down syndrome","volume":"10","author":"Del Hoyo Soriano","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib60","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-141254","article-title":"Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1\/BVR-a system: insights for transition to Alzheimer's disease","volume":"44","author":"Di Domenico","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000514437","article-title":"Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society","volume":"12","author":"Dierssen","year":"2021","journal-title":"Mol. Syndr."},{"key":"10.1016\/j.neubiorev.2024.105794_bib62","doi-asserted-by":"crossref","unstructured":"Do C., Xing Z., Yu Y.E., Tycko B. Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models [published correction appears in Epigenomics. 2017 Mar; 9(3): 369]. Epigenomics. 2017; 9(2): 189-207. DOI:10.2217\/epi-2016-0138.","DOI":"10.2217\/epi-2016-0138"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0921-8777(98)00042-1","article-title":"Defective repair of oxidative damage in mitochondrial DNA in Down's syndrome","volume":"409","author":"Druzhyna","year":"1998","journal-title":"Mutat. Res"},{"key":"10.1016\/j.neubiorev.2024.105794_bib64","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2016.00104","article-title":"DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome","volume":"10","author":"Duchon","year":"2016","journal-title":"Front Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s11689-015-9101-1","article-title":"Psychiatric disorders in adolescents and young adults with Down syndrome and other intellectual disabilities","volume":"7","author":"Dykens","year":"2015","journal-title":"J. Neurodev. Disord."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib66","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2788.2010.01278.x","article-title":"Neuropsychological components of intellectual disability: the contributions of immediate, working, and associative memory [published correction appears in J Intellect Disabil Res. 2011 Feb; 55(2): 252].","volume":"54","author":"Edgin","year":"2010","journal-title":"J. Intellect. Disabil. Res."},{"issue":"8","key":"10.1016\/j.neubiorev.2024.105794_bib67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/15592294.2016.1192736","article-title":"Epigenetic dysregulation in the developing Down syndrome cortex","volume":"11","author":"El Hajj","year":"2016","journal-title":"Epigenetics"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib68","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10072-021-05091-8","article-title":"COVID-19 in patients with Down syndrome","volume":"42","author":"Emami","year":"2021","journal-title":"Neurol. Sci."},{"issue":"21","key":"10.1016\/j.neubiorev.2024.105794_bib69","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.3390\/jcm10215125","article-title":"COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey","volume":"10","author":"Emes","year":"2021","journal-title":"J. Clin. Med"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib70","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1471-4159.2003.01614.x","article-title":"Molecular changes in fetal Down syndrome brain","volume":"84","author":"Engidawork","year":"2003","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neubiorev.2024.105794_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6241017","article-title":"Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders","volume":"2018","author":"Enogieru","year":"2018","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.neubiorev.2024.105794_bib72","series-title":"The Metabolic & Molecular Bases of Inherited Disease","first-page":"1223","article-title":"editors","author":"Epstein","year":"2001"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib73","first-page":"62","article-title":"DSCR1(Adapt78) modulates expression of SOD1","volume":"18","author":"Ermak","year":"2004","journal-title":"FASEB J. 2004 Feb; 18(2): iv]. FASEB J."},{"issue":"C","key":"10.1016\/j.neubiorev.2024.105794_bib74","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0074-7750(10)39004-5","article-title":"Health conditions associated with aging and end of life of adults with Down syndrome","volume":"39","author":"Esbensen","year":"2010","journal-title":"Int Rev. Res Ment. Retard"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib75","article-title":"Down Syndrome and COVID-19: A Perfect Storm?","volume":"1","author":"Espinosa","year":"2020","journal-title":"Cell Rep. Med"},{"issue":"8384","key":"10.1016\/j.neubiorev.2024.105794_bib76","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(84)92325-0","article-title":"Thymic hormone deficiency in normal ageing and Down's syndrome: is there a primary failure of the thymus?","volume":"1","author":"Fabris","year":"1984","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13072-022-00471-6","article-title":"Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain","volume":"15","author":"Farley","year":"2022","journal-title":"Epigenetics Chromatin"},{"issue":"10","key":"10.1016\/j.neubiorev.2024.105794_bib78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/brainsci8100187","article-title":"DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome","volume":"8","author":"Feki","year":"2018","journal-title":"Brain Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib79","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/genes12020268","article-title":"Autoimmunity and Genetic Syndromes: A Focus on Down Syndrome","volume":"12","author":"Ferrari","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.neubiorev.2024.105794_bib80","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/archdischild-2018-315751","article-title":"Musculoskeletal anomalies in children with Down syndrome: an observational study","volume":"104","author":"Foley","year":"2019","journal-title":"Arch. Dis. Child."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib81","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/genes14040800","article-title":"Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes","volume":"14","author":"Fosu","year":"2023","journal-title":"Genes (Basel)"},{"issue":"Pt 3","key":"10.1016\/j.neubiorev.2024.105794_bib82","first-page":"169","article-title":"Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects","volume":"32","author":"Franceschi","year":"1988","journal-title":"J. Ment. Defic. Res"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12903","article-title":"Accelerated bio-cognitive aging in Down syndrome: State of the art and possible deceleration strategies","volume":"18","author":"Franceschi","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.neubiorev.2024.105794_bib84","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fmed.2018.00061","article-title":"The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates","volume":"5","author":"Franceschi","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib85","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4049\/jimmunol.126.6.2161","article-title":"Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome","volume":"126","author":"Franceschi","year":"1981","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib86","first-page":"179","article-title":"T and B lypmhocyte subpopulations in Down's syndrome. A study on non-institutionalised subjects","volume":"22","author":"Franceschi","year":"1978","journal-title":"J. Ment. Defic. Res"},{"key":"10.1016\/j.neubiorev.2024.105794_bib87","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/978-1-4684-5730-8_76","article-title":"Oxidative stress, poly(ADP)ribosylation and aging: in vitro studies on lymphocytes from normal and Down's syndrome subjects of different age and from patients with Alzheimer's dementia","volume":"264","author":"Franceschi","year":"1990","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.neubiorev.2024.105794_bib88","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1749-6632.1991.tb16997.x","article-title":"Aging, longevity, and cancer","volume":"621","author":"Franceschi","year":"1991","journal-title":"Stud. 'S. Syndr. Centen. Ann. NY Acad. Sci."},{"key":"10.1016\/j.neubiorev.2024.105794_bib89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.1992.tb38643.x","article-title":"Genomic instability and aging. Studies in centenarians (successful aging) and in patients with Down's syndrome (accelerated aging)","volume":"663","author":"Franceschi","year":"1992","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1096-8628(19981116)80:3<213::AID-AJMG6>3.0.CO;2-8","article-title":"Population-based study of congenital heart defects in Down syndrome","volume":"80","author":"Freeman","year":"1998","journal-title":"Am. J. Med Genet"},{"issue":"21","key":"10.1016\/j.neubiorev.2024.105794_bib91","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3109\/09638281003734367","article-title":"Quantifying established clinical assessment measures using 3D-movement analysis in individuals with Down syndrome","volume":"32","author":"Galli","year":"2010","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.neubiorev.2024.105794_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mito.2022.11.003","article-title":"Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome","volume":"68","author":"Ganguly","year":"2023","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neubiorev.2024.105794_bib93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2017.06.010","article-title":"Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes","volume":"106","author":"Garc\u00eda-Cerro","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105794_bib94","first-page":"1493","article-title":"Down's syndrome: a ten-year group study","volume":"9","author":"Gaynon","year":"1977","journal-title":"Ann. Ophthalmol."},{"issue":"9-10","key":"10.1016\/j.neubiorev.2024.105794_bib95","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/dneu.22726","article-title":"Down syndrome as a genetic model to evaluate the role of oxidative stress and transsulfuration abnormalities in autism spectrum disorder: A 10-year longitudinal cohort study","volume":"79","author":"Geier","year":"2019","journal-title":"Dev. Neurobiol."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib96","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00281-020-00804-1","article-title":"Down syndrome, accelerated aging and immunosenescence","volume":"42","author":"Gensous","year":"2020","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.neubiorev.2024.105794_bib97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-981-13-3681-2_7","article-title":"Down Syndrome, Ageing and Epigenetics","volume":"91","author":"Gensous","year":"2019","journal-title":"Subcell. Biochem"},{"issue":"24","key":"10.1016\/j.neubiorev.2024.105794_bib98","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.3390\/cells11244044","article-title":"A Targeted Epigenetic Clock for the Prediction of Biological Age","volume":"11","author":"Gensous","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105794_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113111","article-title":"Age-related changes of adaptive and neuropsychological features in persons with Down Syndrome","volume":"9","author":"Ghezzo","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S0016672310000224","article-title":"Chromosome 21 non-disjunction and Down syndrome birth in an Indian cohort: analysis of incidence and aetiology from family linkage data","volume":"92","author":"Ghosh","year":"2010","journal-title":"Genet Res (Camb. )"},{"issue":"10","key":"10.1016\/j.neubiorev.2024.105794_bib101","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/gerona\/glz293","article-title":"Prevalence and Loads of Torquetenovirus in the European MARK-AGE Study Population","volume":"75","author":"Giacconi","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"issue":"14","key":"10.1016\/j.neubiorev.2024.105794_bib102","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.3390\/jcm10143012","article-title":"Sleep Disorders in Adults with Down Syndrome","volume":"10","author":"Gim\u00e9nez","year":"2021","journal-title":"J. Clin. Med"},{"issue":"10","key":"10.1016\/j.neubiorev.2024.105794_bib103","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.5664\/jcsm.7382","article-title":"Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings","volume":"14","author":"Gim\u00e9nez","year":"2018","journal-title":"J. Clin. Sleep. Med"},{"issue":"7","key":"10.1016\/j.neubiorev.2024.105794_bib104","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCRESAHA.118.312562","article-title":"Genetics of Human Longevity Within an Eco-Evolutionary Nature-Nurture Framework","volume":"123","author":"Giuliani","year":"2018","journal-title":"Circ. Res"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00005072-199409000-00011","article-title":"Development of the superior temporal neocortex is anomalous in trisomy 21","volume":"53","author":"Golden","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib106","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.exger.2006.11.016","article-title":"Aging and T-cell diversity.","volume":"42","author":"Goronzy","year":"2007","journal-title":"Exp. Gerontol."},{"issue":"14","key":"10.1016\/j.neubiorev.2024.105794_bib107","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.2020.3514","article-title":"Diagnosis and Management of Obstructive Sleep Apnea: A Review","volume":"323","author":"Gottlieb","year":"2020","journal-title":"JAMA"},{"issue":"5-6","key":"10.1016\/j.neubiorev.2024.105794_bib108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0753-3322(94)90138-4","article-title":"Cell damage by excess CuZnSOD and Down's syndrome","volume":"48","author":"Groner","year":"1994","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.neubiorev.2024.105794_bib109","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G glycosylation in aging and diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell Immunol."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib110","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2012.01.007","article-title":"DYRK1A: a master regulatory protein controlling brain growth [published correction appears in Neurobiol Dis. 2012 Aug; 47(2): 294]","volume":"46","author":"Guedj","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib111","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","article-title":"Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome","volume":"18","author":"Guidi","year":"2008","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib112","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1203\/01.pdr.0000190580.88391.9a","article-title":"Biometry of face and brain in fetuses with trisomy 21","volume":"59","author":"Guihard-Costa","year":"2006","journal-title":"Pedia Res"},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105794_bib113","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2016.23","article-title":"Low risk of solid tumors in persons with Down syndrome","volume":"18","author":"Hasle","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.neubiorev.2024.105794_bib114","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/35066065","article-title":"To err (meiotically) is human: the genesis of human aneuploidy","volume":"2","author":"Hassold","year":"2001","journal-title":"Nat. Rev. Genet"},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrendo.2009.80","article-title":"Endocrine and musculoskeletal abnormalities in patients with Down syndrome","volume":"5","author":"Hawli","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105794_bib116","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1523\/JNEUROSCI.5107-04.2005","article-title":"ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons","volume":"25","author":"Helguera","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib117","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","article-title":"Adaptive downregulation of mitochondrial function in down syndrome","volume":"17","author":"Helguera","year":"2013","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib118","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.a.31442","article-title":"Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system","volume":"143A","author":"Henry","year":"2007","journal-title":"Am. J. Med Genet A"},{"key":"10.1016\/j.neubiorev.2024.105794_bib119","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.sleep.2016.10.001","article-title":"Prevalence and predictors of obstructive sleep apnoea in young children with Down syndrome [published correction appears in Sleep Med. 2017 Jun; 34: 249]","volume":"27-28","author":"Hill","year":"2016","journal-title":"Sleep. Med"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1525","article-title":"Origins of leukaemia in children with Down syndrome","volume":"5","author":"Hitzler","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib122","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5664\/jcsm.3618","article-title":"High prevalence of sleep disorders and associated comorbidities in a community sample of children with Down syndrome","volume":"10","author":"Hoffmire","year":"2014","journal-title":"J. Clin. Sleep. Med"},{"issue":"4173","key":"10.1016\/j.neubiorev.2024.105794_bib123","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.187.4173.226","article-title":"DNA modification mechanisms and gene activity during development","volume":"187","author":"Holliday","year":"1975","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib124","first-page":"6","article-title":"Gastrointestinal disorders in Down syndrome","volume":"7","author":"Holmes","year":"2014","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"10.1016\/j.neubiorev.2024.105794_bib125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/acel.12325","article-title":"Accelerated epigenetic aging in Down syndrome","volume":"14","author":"Horvath","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.neubiorev.2024.105794_bib126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fped.2020.00073","article-title":"Immune Dysregulation in Children With Down Syndrome","volume":"8","author":"Huggard","year":"2020","journal-title":"Front Pedia"},{"key":"10.1016\/j.neubiorev.2024.105794_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100769","article-title":"Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey","volume":"33","author":"H\u00fcls","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.neubiorev.2024.105794_bib128","series-title":"In Management of Genetic Syndromes","article-title":"Down Syndrome","author":"Hunter","year":"2005"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1515\/hsz-2013-0271","article-title":"Citrate--new functions for an old metabolite","volume":"395","author":"Iacobazzi","year":"2014","journal-title":"Biol. Chem."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12017-021-08651-5","article-title":"Specific Susceptibility to COVID-19 in Adults with Down Syndrome [published correction appears in Neuromolecular Med. 2021 May 4;:] [published correction appears in Neuromolecular Med. 2021 Nov 19;:]","volume":"23","author":"Illouz","year":"2021","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.neubiorev.2024.105794_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621440","article-title":"Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome","volume":"12","author":"Illouz","year":"2021","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105794_bib132","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jalz.2016.05.001","article-title":"An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation","volume":"12","author":"Iulita","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib133","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol. Med"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib134","doi-asserted-by":"crossref","DOI":"10.1007\/s002469910025","article-title":"Distribution of symptomatic congenital heart disease in Hong Kong","volume":"21","author":"Jacobs","year":"2000","journal-title":"Pedia Cardiol."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib135","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm.4324","article-title":"Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment","volume":"23","author":"Jeon","year":"2017","journal-title":"Nat. Med"},{"issue":"7462","key":"10.1016\/j.neubiorev.2024.105794_bib136","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nature12394","article-title":"Translating dosage compensation to trisomy 21","volume":"500","author":"Jiang","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003515","article-title":"Global DNA Hypermethylation in Down Syndrome Placenta","volume":"9","author":"Jin","year":"2013","journal-title":"PLoS Genet"},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105794_bib138","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.17219\/acem\/112785","article-title":"Down syndrome as a cause of abnormalities in the craniofacial region: A systematic literature review","volume":"28","author":"Kaczorowska","year":"2019","journal-title":"Adv. Clin. Exp. Med"},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105794_bib139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1101\/gad.349000.121","article-title":"Functional rejuvenation of aged neural stem cells by Plagl2 and anti-Dyrk1a activity","volume":"36","author":"Kaise","year":"2022","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib140","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0030-6665(05)70281-4","article-title":"Otolaryngologic manifestations of Down syndrome","volume":"33","author":"Kanamori","year":"2000","journal-title":"Otolaryngol. Clin. North Am."},{"key":"10.1016\/j.neubiorev.2024.105794_bib141","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cellimm.2017.05.008","article-title":"Role of CD11c+ T-bet+ B cells in human health and disease","volume":"321","author":"Karnell","year":"2017","journal-title":"Cell Immunol."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib142","first-page":"125","article-title":"Down Syndrome: Current Status, Challenges and Future Perspectives","volume":"5","author":"Kazemi","year":"2016","journal-title":"Int J. Mol. Cell Med"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib143","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood-2008-08-170928","article-title":"Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia","volume":"113","author":"Kearney","year":"2009","journal-title":"Blood"},{"issue":"64","key":"10.1016\/j.neubiorev.2024.105794_bib144","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh0891","article-title":"The expansion of human T-bethighCD21low B cells is T cell dependent","volume":"6","author":"Keller","year":"2021","journal-title":"Sci. Immunol."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib145","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","article-title":"Geroscience: linking aging to chronic disease","volume":"159","author":"Kennedy","year":"2014","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105794_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001212","article-title":"Altered DNA methylation in leukocytes with trisomy 21","volume":"6","author":"Kerkel","year":"2010","journal-title":"PLoS Genet"},{"issue":"7","key":"10.1016\/j.neubiorev.2024.105794_bib147","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41584-023-00970-0","article-title":"Down syndrome: insights into autoimmune mechanisms","volume":"19","author":"Khor","year":"2023","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.neubiorev.2024.105794_bib148","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/978-94-007-0753-5_426","article-title":"Cognitive function","author":"Kiely","year":"2014","journal-title":"Encycl. Qual. Life Well-Being Res."},{"issue":"24","key":"10.1016\/j.neubiorev.2024.105794_bib149","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/S0024-3205(01)01074-8","article-title":"The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease","volume":"68","author":"Kim","year":"2001","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.neubiorev.2024.105794_bib150","article-title":"Growth of the hard palate in infants with Down syndrome compared with healthy infants-A retrospective case control study [published correction appears in PLoS One. 2018 Sep 7; 13(9): e0203899]","volume":"12","author":"Klingel","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib151","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10875-020-00803-9","article-title":"Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome","volume":"40","author":"Kong","year":"2020","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib152","first-page":"236","article-title":"Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype","volume":"47","author":"Korenberg","year":"1990","journal-title":"Am. J. Hum. Genet"},{"issue":"10","key":"10.1016\/j.neubiorev.2024.105794_bib153","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.mod.2003.07.001","article-title":"Developmental role of HMGN proteins in Xenopus laevis","volume":"120","author":"K\u00f6rner","year":"2003","journal-title":"Mech. Dev."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib154","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1530\/EJE-09-0606","article-title":"Treated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study","volume":"161","author":"Kramer","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"14","key":"10.1016\/j.neubiorev.2024.105794_bib155","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1523\/JNEUROSCI.2967-17.2018","article-title":"Glutathione Conjugation at the Blood-CSF Barrier Efficiently Prevents Exposure of the Developing Brain Fluid Environment to Blood-Borne Reactive Electrophilic Substances","volume":"38","author":"Kratzer","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2024.105794_bib156","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neures.2018.09.007","article-title":"Triple play of DYRK1A kinase in cortical progenitor cells of Trisomy 21","volume":"138","author":"Kurabayashi","year":"2019","journal-title":"Neurosci. Res"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib157","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","article-title":"Intrinsic defect of the immune system in children with Down syndrome: a review","volume":"156","author":"Kusters","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"14","key":"10.1016\/j.neubiorev.2024.105794_bib158","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1093\/hmg\/ddt125","article-title":"Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome","volume":"22","author":"Laguna","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neubiorev.2024.105794_bib159","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1002\/ajmg.a.34284","article-title":"Natural outcome of trisomy 13, trisomy 18, and triploidy after prenatal diagnosis","volume":"155","author":"Lakovschek","year":"2011","journal-title":"Am. J. Med. Genet."},{"issue":"627","key":"10.1016\/j.neubiorev.2024.105794_bib160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi4888","article-title":"Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity","volume":"14","author":"Lambert","year":"2022","journal-title":"Sci. Transl. Med"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib161","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3201\/eid2901.220530","article-title":"Risk for Severe Illness and Death among Pediatric Patients with Down Syndrome Hospitalized for COVID-19, Brazil","volume":"29","author":"Leung","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.neubiorev.2024.105794_bib162","series-title":"Neuropsychology assessment","first-page":"768","author":"Lezak","year":"1983"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib163","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/WNR.0b013e32834f4eb4","article-title":"miRNA-155 upregulation and complement factor H deficits in Down's syndrome","volume":"23","author":"Li","year":"2012","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib164","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.stem.2012.08.004","article-title":"Trisomy correction in Down syndrome induced pluripotent stem cells","volume":"11","author":"Li","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0008-8749(83)90310-6","article-title":"Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects","volume":"75","author":"Licastro","year":"1983","journal-title":"Cell Immunol."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib166","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1037\/a0024238","article-title":"Hearing loss and cognition in the Baltimore Longitudinal Study of Aging","volume":"25","author":"Lin","year":"2011","journal-title":"Neuropsychology"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib167","first-page":"382","article-title":"Congenital cardiovascular malformations in Chinese children with Down's syndrome","volume":"102","author":"Lo","year":"1989","journal-title":"Chin. Med J. (Engl. )"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib168","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2012.94","article-title":"Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening","volume":"21","author":"Loane","year":"2013","journal-title":"Eur. J. Hum. Genet"},{"key":"10.1016\/j.neubiorev.2024.105794_bib169","doi-asserted-by":"crossref","DOI":"10.1111\/dmcn.15517","article-title":"State-of-the-art therapy for Down syndrome","author":"Lorenzon","year":"2023","journal-title":"Dev. Med Child Neurol."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bbadis.2011.12.010","article-title":"Antioxidants in Down syndrome","volume":"1822","author":"Lott","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.neubiorev.2024.105794_bib171","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-54299-1.00006-6","article-title":"Neurological phenotypes for Down syndrome across the life span","volume":"197","author":"Lott","year":"2012","journal-title":"Prog. Brain Res"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib172","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1755738019886612","article-title":"Down\u2019s syndrome","volume":"13","author":"MacLennan","year":"2020","journal-title":"InnovAiT"},{"issue":"7","key":"10.1016\/j.neubiorev.2024.105794_bib173","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41577-022-00745-w","article-title":"COVID-19 and Down syndrome: the spark in the fuel","volume":"22","author":"Majithia","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"14","key":"10.1016\/j.neubiorev.2024.105794_bib174","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1182\/blood-2013-05-503011","article-title":"Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes","volume":"122","author":"Malinge","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib175","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41436-020-01004-w","article-title":"Individuals with Down syndrome hospitalized with COVID-19 have more severe disease","volume":"23","author":"Malle","year":"2021","journal-title":"Genet Med"},{"issue":"7951","key":"10.1016\/j.neubiorev.2024.105794_bib176","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41586-023-05736-y","article-title":"Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells.","volume":"615","author":"Malle","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2024.105794_bib177","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3389\/fimmu.2019.00447","article-title":"Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development","volume":"10","author":"Marcovecchio","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib178","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2012.12.087","article-title":"Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study","volume":"163","author":"M\u00e5rild","year":"2013","journal-title":"J. Pedia"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib179","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13052-019-0672-4","article-title":"Distribution and age of onset of psychopathological risk in a cohort of children with Down syndrome in developmental age","volume":"45","author":"Marino","year":"2019","journal-title":"Ital. J. Pedia"},{"issue":"14","key":"10.1016\/j.neubiorev.2024.105794_bib180","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3390\/nu14142880","article-title":"Fatty Acids: A Safe Tool for Improving Neurodevelopmental Alterations in Down Syndrome?","volume":"14","author":"Mart\u00ednez-Cu\u00e9","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.neubiorev.2024.105794_bib181","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/ajmg.a.31494","article-title":"CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down Syndrome","volume":"140","author":"Maslen","year":"2006","journal-title":"Am. J. Med. Genet. Part A."},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105794_bib182","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/jir.12390","article-title":"A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome","volume":"61","author":"McCarron","year":"2017","journal-title":"J. Intellect. Disabil. Res"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib183","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s40200-022-01087-z","article-title":"Differential expression of cystathionine beta synthase in adolescents with Down syndrome: impact on adiposity","volume":"21","author":"Meguid","year":"2022","journal-title":"J. Diabetes Metab. Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib184","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1542\/peds.52.4.542","article-title":"Mental and developmental milestones of noninstitutionalized Down's syndrome children","volume":"52","author":"Melyn","year":"1973","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2024.105794_bib185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13059-015-0827-6","article-title":"Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models [published correction appears in Genome Biol. 2016; 17(1): 123]","volume":"16","author":"Mendioroz","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.neubiorev.2024.105794_bib186","first-page":"93","article-title":"Individual differences in vocabulary acquisition in children with Down syndrome","volume":"393","author":"Miller","year":"1995","journal-title":"Prog. Clin. Biol. Res"},{"issue":"6 Suppl","key":"10.1016\/j.neubiorev.2024.105794_bib187","doi-asserted-by":"crossref","first-page":"1208S","DOI":"10.1093\/ajcn\/55.6.1208S","article-title":"Apoptosis--programmed cell death: a role in the aging process?.","volume":"55","author":"Monti","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"issue":"16","key":"10.1016\/j.neubiorev.2024.105794_bib188","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.3390\/jcm10163639","article-title":"Blood Biomarkers for Alzheimer's Disease in Down Syndrome","volume":"10","author":"Montoliu-Gaya","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.neubiorev.2024.105794_bib189","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA Methylation and Its Basic Function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacol"},{"issue":"10","key":"10.1016\/j.neubiorev.2024.105794_bib190","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/ajmg.a.35571","article-title":"Trisomy 21 mosaicism and maternal age","volume":"158A","author":"Morris","year":"2012","journal-title":"Am. J. Med Genet A"},{"issue":"Pt 1","key":"10.1016\/j.neubiorev.2024.105794_bib191","first-page":"41","article-title":"Measurements of neuromuscular tone and strength in Down's syndrome children","volume":"26","author":"Morris","year":"1982","journal-title":"J. Ment. Defic. Res"},{"key":"10.1016\/j.neubiorev.2024.105794_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2022.111691","article-title":"Blood circulating miR-28-5p and let-7d-5p associate with premature ageing in Down syndrome","volume":"206","author":"Morsiani","year":"2022","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neubiorev.2024.105794_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105054","article-title":"Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology","volume":"145","author":"Mullins","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2024.105794_bib194","unstructured":"NCT04115878. Medications for Obstructive Sleep Apnea in Children with Down Syndrome (MOSAIC). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04115878 (accessed on 20 April 2023)."},{"key":"10.1016\/j.neubiorev.2024.105794_bib195","unstructured":"NCT04132999. PAP for Children with DS and OSAS. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04132999 (accessed on 20 April 2023)."},{"key":"10.1016\/j.neubiorev.2024.105794_bib196","unstructured":"NCT04198493. Effect of CPAP Treatment in Cognition in Adults with DS and OSA. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04198493 (accessed on 20 April 2023)."},{"key":"10.1016\/j.neubiorev.2024.105794_bib197","unstructured":"NCT04211870. Effects of Photobiomodulation in Children with Down Syndrome and Possible Sleep Bruxism. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04211870 (accessed on 20 April 2023)."},{"key":"10.1016\/j.neubiorev.2024.105794_bib198","unstructured":"NCT04373616. A Study of ACI-24 in Adults with Down Syndrome. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04373616 (accessed on 20 April 2023)."},{"key":"10.1016\/j.neubiorev.2024.105794_bib199","unstructured":"NCT04668001. Transcranial Photobiomodulation with Near-Infrared Light for Language in Individuals with Down Syndrome (TransPhoM-DS). Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/32118086\/ (accessed on 20 April 2023)."},{"key":"10.1016\/j.neubiorev.2024.105794_bib200","unstructured":"NCT04801771. Nerve Stimulation on Cognition & Language in Down Syndrome. 1U01DC019279-01. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04801771 (accessed on 20 April 2023)."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib201","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.pnpbp.2004.12.009","article-title":"Learning and memory as a function of age in Down syndrome: a study using animal-based tasks","volume":"29","author":"Nelson","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-131901","article-title":"Long-term metformin usage and cognitive function among older adults with diabetes","volume":"41","author":"Ng","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"7432","key":"10.1016\/j.neubiorev.2024.105794_bib203","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK and pseudo-starvation","volume":"493","author":"O'Neill","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib204","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41598-022-05825-4","article-title":"Cognitive profiles in children and adolescents with Down syndrome","volume":"12","author":"Onnivello","year":"2022","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.neubiorev.2024.105794_bib205","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1212\/WNL.0000000000004586","article-title":"Metformin vs sulfonylurea use and risk of dementia in US veterans aged \u226565 years with diabetes","volume":"89","author":"Orkaby","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2024.105794_bib206","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1015220","article-title":"Proteomic profiling reveals mitochondrial dysfunction in the cerebellum of transgenic mice overexpressing DYRK1A, a Down syndrome candidate gene","volume":"15","author":"Ortega","year":"2022","journal-title":"Front Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib207","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ajhg.2008.09.010","article-title":"Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome","volume":"83","author":"Ortiz-Abalia","year":"2008","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.neubiorev.2024.105794_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.749480","article-title":"Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review","volume":"12","author":"Osuna-Marco","year":"2021","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib209","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0306-9877(98)90084-6","article-title":"Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: prospects for joint research in pharmacology","volume":"51","author":"Pagano","year":"1998","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.neubiorev.2024.105794_bib210","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2023.1175636","article-title":"The impact of COVID-19 (Coronavirus) on children and young people with Down syndrome in the United Kingdom","volume":"14","author":"Pagnamenta","year":"2023","journal-title":"Front Psychol."},{"key":"10.1016\/j.neubiorev.2024.105794_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2022.03.006","article-title":"CAPE and its synthetic derivative VP961 restore BACH1\/NRF2 axis in Down Syndrome","volume":"183","author":"Pagnotta","year":"2022","journal-title":"Free Radic. Biol. Med"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib212","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009462","article-title":"The etiology of Down syndrome: Maternal MCM9 polymorphisms increase risk of reduced recombination and nondisjunction of chromosome 21 during meiosis I within oocyte","volume":"17","author":"Pal","year":"2021","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib213","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ajmg.a.36861","article-title":"Mosaicism for trisomy 21: a review","volume":"167A","author":"Papavassiliou","year":"2015","journal-title":"Am. J. Med Genet A"},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105794_bib214","first-page":"2525","article-title":"Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on 21q22.13 as critical to the phenotype","volume":"25","author":"Pelleri","year":"2016","journal-title":"Hum. Mol. Genet"},{"issue":"8","key":"10.1016\/j.neubiorev.2024.105794_bib215","article-title":"Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21","volume":"7","author":"Pelleri","year":"2019","journal-title":"Mol. Genet Genom. Med"},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105794_bib216","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/antiox9090779","article-title":"The BACH1\/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia","volume":"9","author":"Perluigi","year":"2020","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.neubiorev.2024.105794_bib217","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.12.05035","article-title":"Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey","volume":"12","author":"Pinku","year":"2022","journal-title":"J. Glob. Health"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib218","first-page":"208","article-title":"Down Syndrome - Genetics and Cardiogenetics","volume":"12","author":"Plaiasu","year":"2017","journal-title":"Maedica (Bucur. )"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib219","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/321262","article-title":"Homocysteine metabolism in children with Down syndrome: in vitro modulation","volume":"69","author":"Pogribna","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.neubiorev.2024.105794_bib220","doi-asserted-by":"crossref","DOI":"10.1038\/nrm2640","article-title":"Epigenetic inheritance during the cell cycle","volume":"10","author":"Probst","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib221","article-title":"Tiny Toes to Tau Tangles: Down's Syndrome and Its Association With Alzheimer's Disease","volume":"14","author":"Puttagunta","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib222","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","article-title":"Infections and immunodeficiency in Down syndrome","volume":"164","author":"Ram","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.neubiorev.2024.105794_bib223","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.792165","article-title":"DNA Methylation Analysis of Ribosomal DNA in Adults With Down Syndrome","volume":"13","author":"Ravaioli","year":"2022","journal-title":"Front Genet"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib224","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1212\/WNL.45.2.356","article-title":"Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry","volume":"45","author":"Raz","year":"1995","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib225","first-page":"9","article-title":"X inactivation, differentiation, and DNA methylation","volume":"14","author":"Riggs","year":"1975","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.neubiorev.2024.105794_bib226","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg1655","article-title":"DNA methylation and human disease","volume":"6","author":"Robertson","year":"2005","journal-title":"Nat. Rev. Genet"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib227","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3934\/Neuroscience.2021015","article-title":"From the lab to the people: major challenges in the biological treatment of Down syndrome","volume":"8","author":"Rondal","year":"2021","journal-title":"AIMS Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib228","article-title":"Altered connectivity of the default mode network in cognitively stable adults with Down syndrome: \"Accelerated aging\" or a prelude to Alzheimer's disease?","volume":"13","author":"Rosas","year":"2021","journal-title":"Alzheimers Dement (Amst."},{"issue":"7","key":"10.1016\/j.neubiorev.2024.105794_bib229","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/jch.13930","article-title":"Adults with Down syndrome challenge another paradigm: When aging no longer entails arterial hypertension","volume":"22","author":"Roy-Vallejo","year":"2020","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"5-6","key":"10.1016\/j.neubiorev.2024.105794_bib230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0921-8734(90)90006-D","article-title":"Age-related increase of mitomycin C-induced micronuclei in lymphocytes from Down's syndrome subjects","volume":"237","author":"Scarf\u00ed","year":"1990","journal-title":"Mutat. Res"},{"key":"10.1016\/j.neubiorev.2024.105794_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147487","article-title":"Mechanisms of human DNA methylation, alteration of methylation patterns in physiological processes and oncology","volume":"875","author":"Sergeeva","year":"2023","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib232","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajmg.c.30095","article-title":"Down syndrome: common otolaryngologic manifestations","volume":"142C","author":"Shott","year":"2006","journal-title":"Am. J. Med Genet C. Semin Med Genet"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib233","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/archotol.132.4.432","article-title":"Obstructive sleep apnea: Should all children with Down syndrome be tested?","volume":"132","author":"Shott","year":"2006","journal-title":"Arch. Otolaryngol. Head. Neck Surg."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib234","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JAD-170624","article-title":"Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome","volume":"61","author":"Sinai","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"5-6","key":"10.1016\/j.neubiorev.2024.105794_bib235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0753-3322(94)90140-6","article-title":"Mapping of the Down syndrome phenotype on chromosome 21 at the molecular level","volume":"48","author":"Sinet","year":"1994","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.neubiorev.2024.105794_bib236","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.903729","article-title":"The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives","volume":"16","author":"Stagni","year":"2022","journal-title":"Front Cell Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib237","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ajpa.22255","article-title":"Trisomy 21 and facial developmental instability","volume":"151","author":"Starbuck","year":"2013","journal-title":"Am. J. Phys. Anthr."},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105794_bib238","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/ajmg.a.38464","article-title":"The Influence of trisomy 21 on facial form and variability","volume":"173","author":"Starbuck","year":"2017","journal-title":"Am. J. Med Genet A."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib239","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s11689-019-9306-9","article-title":"Health comorbidities and cognitive abilities across the lifespan in Down syndrome","volume":"12","author":"Startin","year":"2020","journal-title":"J. Neurodev. Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib240","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/jar.12572","article-title":"Sleep problems in adults with Down syndrome and their family carers","volume":"32","author":"Stores","year":"2019","journal-title":"J. Appl. Res Intellect. Disabil."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib241","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/mgg3.334","article-title":"Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits","volume":"5","author":"Stringer","year":"2017","journal-title":"Mol. Genet Genom. Med"},{"key":"10.1016\/j.neubiorev.2024.105794_bib242","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nprot.2012.012","article-title":"Methylome analysis using MeDIP-seq with low DNA concentrations","volume":"7","author":"Taiwo","year":"2012","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib243","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1073\/pnas.052410099","article-title":"Comprehensive analysis of CpG islands in human chromosomes 21 and 22","volume":"99","author":"Takai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2024.105794_bib244","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.12.003","article-title":"Mitochondrial Dysfunction in Down Syndrome: From Pathology to Therapy","volume":"511","author":"Tan","year":"2023","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105794_bib245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11154-007-9042-4","article-title":"Epigenetic reprogramming and imprinting in origins of disease","volume":"8","author":"Tang","year":"2007","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.neubiorev.2024.105794_bib246","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cct.2017.06.003","article-title":"Building research in diet and cognition: The BRIDGE randomized controlled trial","volume":"59","author":"Tussing-Humphreys","year":"2017","journal-title":"Conte Clin. Trials"},{"key":"10.1016\/j.neubiorev.2024.105794_bib247","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.08.014","article-title":"Mitochondria as pharmacological targets in Down syndrome","volume":"114","author":"Valenti","year":"2018","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.neubiorev.2024.105794_bib248","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pedhc.2005.10.004","article-title":"Part I: clinical practice guidelines for children with Down syndrome from birth to 12 years","volume":"20","author":"Van Cleve","year":"2006","journal-title":"J. Pedia Health Care"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105794_bib249","first-page":"661","article-title":"Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes","volume":"52","author":"Vaziri","year":"1993","journal-title":"Am. J. Hum. Genet"},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105794_bib250","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10875-020-00805-7","article-title":"Inborn Errors of Adaptive Immunity in Down Syndrome","volume":"40","author":"Verstegen","year":"2020","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib251","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2788.2009.01158.x","article-title":"Down syndrome: a cardiovascular perspective","volume":"53","author":"Vis","year":"2009","journal-title":"J. Intellect. Disabil. Res"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib252","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/gtmb.2011.0066","article-title":"Down syndrome: parental origin, recombination, and maternal age","volume":"16","author":"Vranekovi\u0107","year":"2012","journal-title":"Genet Test. Mol. Biomark."},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105794_bib253","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/bies.10008","article-title":"Methyl CpG-binding proteins and transcriptional repression","volume":"23","author":"Wade","year":"2001","journal-title":"Bioessays"},{"key":"10.1016\/j.neubiorev.2024.105794_bib254","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2147\/CIA.S145247","article-title":"Cognitive and behavioral evaluation of nutritional interventions in rodent models of brain aging and dementia","volume":"12","author":"Wahl","year":"2017","journal-title":"Clin. Inter. Aging"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105794_bib255","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ridd.2011.02.010","article-title":"Depression in Down syndrome: a review of the literature","volume":"32","author":"Walker","year":"2011","journal-title":"Res Dev. Disabil."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib256","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/s41467-018-03750-7","article-title":"IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib257","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","article-title":"Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome","volume":"32","author":"Wechsler","year":"2002","journal-title":"Nat. Genet"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib258","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MED.0000000000000382","article-title":"Endocrine manifestations of Down syndrome","volume":"25","author":"Whooten","year":"2018","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.neubiorev.2024.105794_bib259","first-page":"274","article-title":"Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis","volume":"7","author":"Wisniewski","year":"1990","journal-title":"Am. J. Med Genet Suppl."},{"key":"10.1016\/j.neubiorev.2024.105794_bib260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jbiotec.2017.08.007","article-title":"Strategies for analyzing bisulfite sequencing data","volume":"261","author":"Wreczycka","year":"2017","journal-title":"J. Biotechnol."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105794_bib261","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3164\/jcbn.09-104-2","article-title":"Superoxide anion, uncoupling proteins and Alzheimer's disease","volume":"46","author":"Wu","year":"2010","journal-title":"J. Clin. Biochem Nutr."},{"issue":"7","key":"10.1016\/j.neubiorev.2024.105794_bib262","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13652","article-title":"Accelerated epigenetic aging in newborns with Down syndrome","volume":"21","author":"Xu","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.neubiorev.2024.105794_bib263","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13072-016-0075-3","article-title":"Profiling genome-wide DNA methylation","volume":"9","author":"Yong","year":"2016","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.neubiorev.2024.105794_bib264","first-page":"628","article-title":"Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of the chromosomal error: a population-based study","volume":"58","author":"Yoon","year":"1996","journal-title":"Am. J. Med Genet"},{"key":"10.1016\/j.neubiorev.2024.105794_bib265","first-page":"1","article-title":"Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models","volume":"251","author":"Yu","year":"2020","journal-title":"Prog. Brain Res"},{"issue":"23","key":"10.1016\/j.neubiorev.2024.105794_bib266","doi-asserted-by":"crossref","first-page":"24057","DOI":"10.18632\/aging.202251","article-title":"Age-related DNA methylation changes are sex-specific: a comprehensive assessment","volume":"12","author":"Yusipov","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105794_bib267","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.freeradbiomed.2009.02.006","article-title":"Epigenetics, oxidative stress, and Alzheimer disease","volume":"46","author":"Zawia","year":"2009","journal-title":"Free Radic. Biol. Med"},{"issue":"48","key":"10.1016\/j.neubiorev.2024.105794_bib268","doi-asserted-by":"crossref","first-page":"84489","DOI":"10.18632\/oncotarget.21060","article-title":"Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib269","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00198-021-06070-7","article-title":"Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis","volume":"33","author":"Zhang","year":"2022","journal-title":"Osteoporos. Int"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ddrr.1128","article-title":"Atypical aging in Down syndrome","volume":"18","author":"Zigman","year":"2013","journal-title":"Dev. Disabil. Res Rev."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105794_bib271","article-title":"Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome","volume":"19","author":"Zipursky","year":"1999","journal-title":"Clin. Lab Med"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976342400263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976342400263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:31:54Z","timestamp":1777491114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014976342400263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":271,"alternative-id":["S014976342400263X"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105794","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intricacies of aging and Down syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105794"}}